Get started
Author

Ivan V. Lyagoskin

Observed names: I. Lyagoskin, I. V. Lyagoskin, I.V. Lyagoskin, Ivan Lyagoskin, Ivan S. Lyagoskin, И. В. Лягоскин, Лягоскин И. В., Лягоскин Иван Владимирович
Observed institution: Generium Pharmaceuticals (Russia)
ORCID: 0000-0002-9058-1106
Observed ORCID: 0000-0002-9058-1106
OpenAlex ID: A5060029889
Analytical and functional similarity of biosimilar Elizaria® with eculizumab reference product
2022 · Valentina Gusarova, Maxim Degterev, et al. · Journal of Pharmaceutical and Biomedical Analysis · 18
Characterization of a HIR-Fab-IDS, Novel Iduronate 2-Sulfatase Fusion Protein for the Treatment of Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome)
2023 · Valentina D. Gusarova, Maxim A. Smolov, et al. · BioDrugs · 8
Safety, tolerability, and pharmacokinetics of verenafusp alfa in healthy volunteers: results of an open-label multicohort phase I study
2026 · Elena A. Smolyarchuk, Susanna S. Sologova, et al. · Terapevticheskii arkhiv · 2
PDF
Physicochemical and Biological Characterization of rhC1INH Expressed in CHO Cells
2021 · Ekaterina Zubareva, Maksim Degterev, et al. · Pharmaceuticals · 2
PDF
Method development and validation for determination of antihemolytic activity of eculizumab (Soliris)
2016 · E. Yu. Prudnikova, G. N. Poroshin, et al. · Pharmacy & Pharmacology · 2
PDF
Interim results of a multicenter, open-label, multicohort study of enzyme replacement therapy with Verenafusp Alfa in patients under 18 years of age with Mucopolysaccharidosis Type II
2026 · L.S. Namazova-Baranova, N.D. Vashakmadze, et al. · PEDIATRIA Journal named after G N SPERANSKY · 1
Comparative Characterization of a Proposed Generic Nusinersen: Identity of the Oligonucleotide Structure and Equivalence in SMN2 Splicing Activity
2026 · Serge Taran, Maksim Smolov, et al. · Pharmaceutics · 1
PDF
Validation of an Analytical Procedure for Evaluating the Biological Activity of a Medicinal Product Based on Tocilizumab and Determination of Acceptance Criteria for Test Results
2024 · Yu. A. Nikonova, S. G. Abbasova, et al. · Ведомости Научного центра экспертизы средств медицинского применения · 1
PDF
Optimization and validation of flow cytometry method for quantification of SARS-CoV-2 antigen-reactive human memory T cells
2023 · Olga M. Strizhakova, Andrey S. Pershin, et al. · Russian Journal of Infection and Immunity · 1
PDF
Intra-laboratory validated “TigraTest® SARS-CoV-2” — test assessing release of interferon gamma in vitro to identify peripheral blood T-lymphocytes specifically responding against SARS-CoV-2 virus antigens
2022 · Ivan V. Lyagoskin, Pauline E. Kargopolova, et al. · Russian Journal of Infection and Immunity · 1
PDF
Development and Validation of a Biolayer Interferometry Method for Determination of Human Anti-PD-1 Monoclonal Antibody Concentration in Cynomolgus Serum
2020 · K. V. Ulyanova, A. A. Kazarov, et al. · Biological Products Prevention Diagnosis Treatment · 1
Валидация XTT-теста для оценки антипролиферативной активности препаратов на основе моноклональных антител
2015 · И. В. Лягоскин, М. А. Берестовой, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
Analytical Characterization, Pharmacokinetics, Safety, and Preliminary Immunogenicity of GNR-062, an Agalsidase Beta Biosimilar Candidate, in Healthy Male Volunteers
2026 · Ivan Lyagoskin, Maksim Smolov, et al. · BioTech
Comparative Analysis of SMN2 Splicing Activity and Protein Production Following In Vitro Treatment with the Generic Risdiplam Drug Vapromin® and the Reference Drug Evrysdi®
2026 · Olga Strizhakova, Andrei Pershin, et al. · Biomedicines
An Open-Label, Comparative, Parallel Clinical Trial of the Safety, Pharmacokinetics and Immunogenicity of the Ustekinumab Biosimilar GNR-068 and the Originally Developed Ustekinumab as a Reference Drug After a Single Subcutaneous Administration in Healthy Male Volunteers
2026 · Ivan Lyagoskin, Alena Agafonova, et al. · Antibodies
Development and Validation of Cell-Based Bioassay for the Detection of Neutralizing Antibodies to Ocrelizumab in Human Serum Using Antibody-Dependent Cell-Mediated Cytotoxicity Test in a Reporter Cell Line Expressing FcγRIIIa
2026 · Olga Strizhakova, Grigory Poroshin, et al. · Antibodies
Physicochemical and biological characterization of GNR-087, a Tocilizumab biosimilar
2026 · Valentina D. Gusarova, Ivan V. Lyagoskin, et al. · Journal of Pharmaceutical and Biomedical Analysis
Detection of anti-drug antibodies to aflibercept by enzyme-linked immunosorbent assay: Development and validation of the method
2025 · I. V. Shevchenko, A. E. Lisova, et al. · Biological Products Prevention Diagnosis Treatment
Validation of a biolayer interferometry-based method for the determination of binding (total) antibodies to romiplostim in human serum
2025 · A. A. Agafonova, M. V. Zhilyaeva, et al. · Biological Products Prevention Diagnosis Treatment
PDF
Development and validation of an analytical procedure for the determination of residual protein A in active substances of therapeutic monoclonal antibodies
2024 · E. V. Nozdrina, D. A. Mazalev, et al. · Biological Products Prevention Diagnosis Treatment
PDF
Comparative physicochemical and biological characterization of the similar imiglucerase product Glurazyme® and the originator product Cerezyme®
2023 · Maksim Smolov, Serge Taran, et al. · Journal of Pharmaceutical and Biomedical Analysis Open
Comparative Immunogenicity of the Gam-COVID-Vac Vaccine under Intranasal and Intramuscular Administration
2023 · E. I. Katorkina, I. V. Lyagoskin, et al. · Journal Biomed
Сопоставимость функциональных свойств разрабатываемого биоаналогичного препарата GNR-069 и референтного лекарственного препарата Энплейт® in vitro
2023 · S. Abbasova, O. Strizhakova, et al. · Биофармацевтический журнал
Internalization of Recombinant Imiglucerase into Mouse Peritoneal Macrophages and L929 Mouse Fibroblasts
2020 · I. V. Lyagoskin, M. S. Pantyushenko, et al. · Biological Products Prevention Diagnosis Treatment
PDF
ОПТИМИЗАЦИЯ И ВАЛИДАЦИЯ КОЛИЧЕСТВЕННОГО МЕТОДА ОЦЕНКИ РЕАКТИВНОСТИ Т-КЛЕТОК ПАМЯТИ ЧЕЛОВЕКА К АНТИГЕНАМ ВИРУСА SARS-CoV-2 С ИСПОЛЬЗОВАНИЕМ ПРОТОЧНОЙ ЦИТОМЕТРИИ
· О. М. Стрижакова, Першин Андрей Сергеевич, et al. · CyberLeninK (CyberLeninka)
Works count: 29
Citation count: 39
H-index: 2
I10-index: 1
Year
Topic
Type